GlaxoSmithKline PLC (NYSE:GSK)

45.51
Delayed Data
As of Dec 06
 +0.30 / +0.66%
Today’s Change
36.41
Today|||52-Week Range
46.01
+19.10%
Year-to-Date
Is Clovis Oncology Really a Buyout Candidate?
Dec 03 / MotleyFool.com - Paid Partner Content
3 Top Growth Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close45.21
Today’s open45.40
Day’s range45.27 - 45.57
Volume2,550,081
Average volume (3 months)2,531,072
Market cap$113.5B
Data as of 6:30pm ET, 12/06/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)+0.96%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+5.72%
P/E ratio19.0
Price/Sales2.31
Price/Book20.17

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.05-0.11%
LLYEli Lilly and Co-0.13-0.11%
NVONovo Nordisk-0.33-0.58%
AZNAstraZeneca+0.06+0.13%
Data as of 6:30pm ET, 12/06/2019

Financials

Next reporting dateFebruary 5, 2020
EPS forecast (this quarter)$0.69
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Brentford, Greater London

Forecasts